The OBD results on predictive biomarkers for treatment of rheumatoid arthritis patients will be presented in a talk by Dr Carl Goodyear (Glasgow University) at The American College of Rheumatology Conference in San Francisco. The study is co-authored with The Scottish Early Rheumatoid Arthritis Consortium, Professor Iain McInnes, Glasgow University and Professor Claudio Carini, Global Head of Biomarkers, Pfizer.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with this.OkRead more